Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes

Phytochemistry

Volumn 71, Issue 17-18, 2010, Pages 2058-2073

  Fischedick, Justin Thomas ^a   Hazekamp, Arno ^a   Erkelens, Tjalling ^b   Choi, Young Hae ^a   Verpoorte, Rob ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Bedrocan BV   (Netherlands)

Author keywords

Cannabinoids; Cannabis; Cannabis sativa; Chemotaxonomy; Gas chromatography; Metabolic fingerprinting; Terpenoids

Indexed keywords

CANNABINOID; CANNABIS; DRUG; TERPENE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; GAS CHROMATOGRAPHY; MEDICINAL PLANT; STANDARD;

CANNABINOIDS; CANNABIS; CHROMATOGRAPHY, GAS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; PLANTS, MEDICINAL; REFERENCE STANDARDS; TERPENES;

CANNABIS; CANNABIS SATIVA;

EID: 78249276186     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2010.10.001     Document Type: Article

References (44)

1. R.P. Adams Identification of Essential Oils by Ion Trap Mass Spectrometry 1989 Academic Press Inc. New York
2. S.A. Ahmed, S.A. Ross, D. Slade, M.M. Radwan, F. Zulfiqar, and M.A. ElSohly Cannabinoid ester constituents from high-potency Cannabis sativa J. Nat. Prod. 71 2008 536 542
3. M. Ben Amar Cannabinoids in medicine: a review of their therapeutic potential J. Ethnopharmacol. 105 2006 1 25
4. C. Bicchi, E. Liberto, M. Matteodo, B. Sgorbini, L. Mondello, B.A. Zellner, R. Costa, and P. Rubiolo Quantitative analysis of essential oils: a complex task Flavour Fragr. J. 23 2008 382 391
5. 1H-NMR spectroscopy and principal components analysis J. Nat. Prod. 67 2004 953 957
6. M.A. ElSohly, and D. Slade Chemical constituents of marijuana: the complex mixture of natural cannabinoids Life Sci. 78 2005 539 548
7. M.A. ElSohly, S.R. Wachtel, and H. de Wit Cannabis versus THC: response to Russo and McPartland Psychopharmacology 165 2003 433 434
8. L. Eriksson, E. Johansson, N. Kettaneh-Wold, J. Tyrgg, C. Wikström, and S. Wold Multi- and Megavariate Data Analysis Part 1: Basic Principles and Applications second ed. 2006 Umetrics Ume, Sweden
9. J.W. Fairbairn, and J.T. Pickens Activity of cannabis in relation to its Δ′-trans-tetrahydrocannabinol content Br. J. Pharmacol. 72 1981 401 409
10. P.S. Fetterman, E.S. Keith, C.W. Waller, O. Guerrero, N.J. Doorenbos, and M.W. Quimby Mississippi-grown Cannabis sativa L. preliminary observation on chemical definition of phenotype and variations in tetrahydrocannabinol content versus age, sex, and plant part J. Pharm. Sci. 60 1971 1246 1477
11. J. Fischedick, F. Van der Kooy, and R. Verpoorte Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor Chem. Pharm. Bull. 58 2010 201 207
12. A. Hazekamp An evaluation of the quality of medicinal grade cannabis in the Netherlands Cannabinoids 1 2006 1 9
13. Hazekamp, A., 2007. Cannabis Extracting the Medicine. Ph.D. Thesis, Universiteit Leiden, Leiden, The Netherlands.
14. A. Hazekamp, and F. Grotenhermen Review on clinical studies with cannabis and cannabinoids 2005-2009 Cannabinoids 5 2010 1 21
15. 1H-NMR Chem. Pharm. Bull. 52 2004 718 721
16. A. Hazekamp, R. Simons, A. Peltenburg-Looman, M. Sengers, R. Van Zweden, and R. Verpoorte Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography J. Liq. Chromatogr. Relat. Technol. 27 2004 2421 2439
17. K.W. Hillig A chemotaxonomic analysis of terpenoid variation in cannabis Biochem. Syst. Ecol. 32 2004 875 891
18. K.W. Hillig, and P.G. Mahlberg A chemotaxonomic analysis of cannabinoid variation in cannabis (cannabaceae) Am. J. Bot. 91 2004 966 975
19. D.E. Hoffmann, and E. Weber Medical marijuana and the law N. Engl. J. Med. 362 2010 1453 1457
20. J.M. Johnson, L. Lemberger, M. Novotny, R.B. Forney, W.S. Dalton, and M.P. Maskarinec Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9- tetrahydrocannabinol in mice Toxicol. Appl. Pharmacol. 72 1984 440 448
21. T. Komori, T. Nohara, I. Hosokawa, and T. Kawasaki Cannabigerol monomethyl ether, a new component of hemp Chem. Pharm. Bull. 16 1968 1164 1165
22. A.B. Llan, A. Gevins, M. Coleman, M.A. ElSohly, and H. de Wit Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids Behav. Pharmacol. 16 2005 487 496
23. T. Malingre, H. Hendricks, S. Batterman, R. Bos, and J. Visser The essential oil of Cannabis sativa Planta Med. 28 1975 56 61
24. J.M. McPartland, and E.B. Russo Cannabis and cannabis extracts: greater then the sum of their parts? J. Cannabis Ther. 1 2001 103 132
25. OMC: Office of Medicinal Cannabis, 2010. Official Website: .
26. R.G. Pertwee Cannabinoid pharmacology: the first 66 years Br. J. Pharmacol. 147 2006 163 171
27. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 156 2009 397 411
28. J.T. Pickens Sedative activity of cannabis in relation to its Δ′-trans-tetrahydrocannabinol and cannabidiol content Br. J. Pharmacol. 72 1981 649 656
29. 9-THC- acid Phytochemistry 69 2008 562 570
30. M.M. Radwan, M.A. ElSohly, D. Slade, S.A. Admed, I.A. Khan, and S.A. Ross Biologically active cannabinoids from high-potency Cannabis sativa J. Nat. Prod. 72 2009 906 911
31. S.A. Ross, and M.A. ElSohly The volatile oil composition of fresh and air-dried buds of Cannabis sativa J. Nat. Prod. 59 1996 49 51
32. M. Rothschild, G. Bergström, and S. Wngberg Cannabis sativa: volatile compounds from pollen and entire male and female plants of two variants, Northern lights and Hawaian indica Bot. J. Linnean Soc. 147 2005 387 397
33. E.B. Russo History of cannabis and its preparations in saga, science, and sobriquet Chem. Biodiversity 4 2007 1614 1648
34. 9-tetrahydrocannabinol Psychopharmacology 165 2003 431 432
35. D. Ryan, A.J. Drysdale, R.G. Pertwee, and B. Platt Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia Neurosci. Lett. 408 2006 236 241
36. A.B. Segelman, R.D. Sofia, F.P. Segelman, J.J. Harakal, and L.C. Knobloch Cannabis sativa L. (marijuana) V: pharmacological evaluation of marijuana aqueous extract and volatile oil J. Pharm. Sci. 26 1974 962 964
37. E. Small, and H.D. Beckstead Cannabinoid phenotypes in Cannabis sativa Nature 245 1973 147 148
38. E. Small, and H.D. Beckstead Common cannabinoid phenotypes in 350 stocks of cannabis Lloydia 36 1973 144 165
39. F. Taura, S. Sirikantaramas, Y. Shoyama, Y. Shoyama, and S. Morimoto Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes Chem. Biodiversity 4 2007 1649 1663
40. F. Van der Kooy, F. Maltese, Y.H. Choi, H.K. Kim, and R. Verpoorte Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting Planta Med. 75 2009 763 775
41. 9-tetrahydrocannabinol and marijuana in humans Psychopharmacology 161 2002 331 339
42. B.J. Whalley, J.D. Wilkinson, E.M. Williamson, and A. Constanti A novel component of cannabis extracts potentiates excitatory synaptic transmission in rat olfactory cortex in vitro Neurosci. Lett. 365 2004 58 63
43. 9- tetrahydrocannabinol necessary for all its effects? J. Pharm. Pharmacol. 55 2003 1687 1694
44. E.M. Williamson, and F.J. Evans Cannabinoids in clinical practice Drugs 60 2000 1303 1314